Welcome to Dwaey, specifically on Bacillus calmette-Guerin strain (BCG vaccine) page.
This medicine contains important and useful components, as it consists of
Bacillus calmette-Guerin strain (BCG vaccine) is available in the market in concentration.
Bacillus calmette-Guerin strain (BCG vaccine)
Before receiving the Bacillus Calmette-Guerin (BCG) vaccine, it is crucial that patients consult their healthcare provider, especially in the following situations:
- Immunocompromised Individuals: The BCG vaccine is a live attenuated vaccine, and patients with weakened immune systems (due to conditions such as HIV infection, cancer, or autoimmune diseases) should not receive the vaccine, as it can cause a severe infection.
- Pregnancy: BCG vaccination is contraindicated during pregnancy. There are limited data on the vaccine’s safety in pregnant women, and live vaccines pose a potential risk to the developing fetus. It is essential to avoid vaccination during pregnancy unless the potential benefits clearly outweigh the risks.
- Severe Allergic Reactions: Any history of severe allergic reactions (anaphylaxis) to a previous BCG dose or any of its components should be discussed with a healthcare provider. In rare cases, severe allergic reactions may occur.
- Pre-existing Skin Conditions: If the individual has pre-existing dermatologic conditions, including eczema, it may increase the risk of developing severe adverse reactions such as skin infections post-vaccination.
- Lactating Women: Although the BCG vaccine is not typically recommended during breastfeeding, the decision should be made based on the specific circumstances of the woman and any potential risks versus benefits.
The BCG vaccine is primarily used for:
- Tuberculosis (TB) Prevention: The vaccine is primarily given to prevent tuberculosis (TB), particularly in countries with high rates of the disease. It helps protect against severe forms of TB, including miliary tuberculosis and TB meningitis in infants and young children.
- Bladder Cancer: BCG is used as a treatment for non-muscle-invasive bladder cancer. It is instilled directly into the bladder to stimulate the immune system and reduce cancer recurrence by inducing a local immune response.
- Leprosy: While not as widely used for this purpose, the BCG vaccine has been used in some settings to provide partial protection against leprosy.
- Other Uses: Some research suggests the BCG vaccine might have broader immune-boosting effects, and studies have explored its use for other conditions, including type 1 diabetes and genitourinary tract infections.
The BCG vaccine should not be administered in the following situations:
- Immunocompromised Patients: Individuals with immunosuppressive conditions, such as those with HIV/AIDS, those undergoing chemotherapy, or those taking immunosuppressive medications, should not receive the vaccine due to the risk of a severe infection.
- Pregnancy: The BCG vaccine is contraindicated during pregnancy as it is a live vaccine. The potential risk to the fetus outweighs the benefits, and it should only be administered when clearly necessary.
- Severe Allergic Reaction: Any person with a history of severe allergic reactions (anaphylaxis) to the BCG vaccine or its components should not receive it.
- Active Tuberculosis: If a person has active TB, the vaccine should not be administered, as it will not treat the active infection and could potentially worsen the condition.
- Severe Dermatological Conditions: Active eczema or other skin diseases should be considered a contraindication, as BCG vaccination can cause severe skin reactions in such individuals.
The side effects of the BCG vaccine can vary, but most individuals tolerate it well. Common and rare side effects include:
- Local Reactions: These are the most common and typically include:
- Redness, swelling, and pain at the site of injection.
- Abscess or ulcer formation at the injection site, particularly in individuals with pre-existing skin conditions.
- Fever: A mild fever may develop following vaccination, which usually resolves within a few days.
- Lymphadenopathy: Swelling of the lymph nodes near the vaccination site may occur, which is a common and usually benign reaction.
- Systemic Reactions: In rare cases, joint pain, muscle aches, or rash may occur.
- Severe Reactions: Although rare, severe adverse effects include:
- Disseminated BCG infection, which can occur in immunocompromised individuals and may involve organs such as the lungs, liver, and spleen.
- Severe allergic reactions (anaphylaxis), although this is rare, it can lead to difficulty breathing and requires immediate medical attention.
3
The BCG vaccine contains live, attenuated (weakened) Mycobacterium bovis bacteria. Upon administration, the vaccine stimulates the body's immune system to recognize and fight the bacteria. The vaccine’s mechanism of action includes:
- Immune Response Activation: After the injection, the body’s immune system recognizes the inactivated bacteria as foreign. This leads to the production of T cells and other immune molecules (like cytokines), which prepare the immune system to recognize and fight off future exposures to Mycobacterium tuberculosis.
- Immune Memory Formation: The vaccine induces immunologic memory, meaning that if a person is later exposed to Mycobacterium tuberculosis, their immune system is prepared to mount a faster and more effective response, helping to prevent severe tuberculosis infections.
In addition to providing protection against tuberculosis, the vaccine’s immune-stimulating properties are leveraged in the treatment of bladder cancer by triggering an immune response within the bladder tissue to fight cancer cells.
While the BCG vaccine generally has few interactions with other medications, several considerations should be kept in mind:
- Immunosuppressive Drugs: Use of immunosuppressive drugs (e.g., corticosteroids, chemotherapeutic agents) concurrently with the BCG vaccine can compromise its effectiveness and increase the risk of adverse reactions.
- Other Vaccines: It is generally recommended to avoid administering other live vaccines (such as measles, mumps, rubella) at the same time as BCG, as there may be an increased risk of adverse effects or reduced effectiveness of one or both vaccines. A gap of at least 4 weeks is recommended before or after receiving a live vaccine.
- BCG and Anti-Tuberculosis Drugs: If an individual is on treatment for active tuberculosis, BCG vaccination should be delayed until the tuberculosis infection is under control, as the vaccine may not be effective in this scenario.
The BCG vaccine is typically administered in a single dose via intracutaneous injection, usually in the upper arm. The dosage remains the same for both adults and children, but healthcare providers may adjust the timing based on local TB rates and the specific purpose of vaccination (e.g., routine TB prevention or cancer therapy).
- Routine Tuberculosis Prevention: One dose, as recommended by national immunization schedules, often in infancy or childhood in areas where tuberculosis is prevalent.
- Bladder Cancer Treatment: For bladder cancer, BCG is administered via intravesical (bladder) instillation. The dosage and frequency will depend on the specific treatment regimen prescribed by the oncologist.
The BCG vaccine dosage for children is typically the same as for adults. Infants are often the primary recipients of the vaccine, especially in regions with high tuberculosis prevalence.
- Routine Vaccination in Infants: Typically administered as a single intradermal dose at birth or shortly after, as per the national immunization schedule in endemic areas.
- In Immunocompetent Children: The dose remains the same, but careful consideration must be given for children with conditions such as eczema, which may increase the risk of side effects like local infections.
As with all vaccinations, it is essential that children undergo a thorough medical evaluation before vaccination to ensure the suitability of BCG, particularly in areas where the vaccine is recommended as part of routine childhood immunization.
No specific renal dose adjustment is required for the BCG vaccine. However, individuals with renal impairment should be evaluated on a case-by-case basis. Since the BCG vaccine involves immune activation, renal function and response to the vaccine should be monitored closely, especially for those who may be receiving the vaccine as part of cancer treatment.